Chi Mei Medical Center

Taikang, Tainan 71004

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Prevention of Stroke or Systemic Embolism, Solid Tumors

Studies at this site

• A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early